Bristol Myers Squibb (BMS) and 2seventy bio’s Abecma have received FDA approval ...
The US FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for adults with...
In the second part of this series, F. Randy Vogenberg talks about how planning e...
J&J and Legend’s CAR-T cell therapy has been approved as a second-line therapy f...
View the leading pharmaceutical solid dose manufacturing companies in contract m...
The FDA has approved the NDA for SH-201, an oral liquid drug that slows or stops...
In an interview with Pharmaceutical Technology, Pluri’s CEO discussed its recent...
Despite a failed bid to expand Imfinzi’s treatment scope in NSCLC, the drug has ...
GSK’s Trelegy Ellipta has been approved as a maintenance therapy for both asthma...
Last month, Amylyx announced that the Phase III confirmatory trial of ALS drug R...
Recent campaigns have targeted children and young adults in low vaccine uptake a...
Acumen has entered a partnership with Lonza to further the development of sabirn...
MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop ...
Caris Life Sciences has entered a collaboration with Merck KGaA for the developm...
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazob...
The director of BARDA’s medical countermeasures programs, Robert Johnson, talks ...
